Biopsy Devices Market Report by Product, Application, Technology, End-User, Countries and Company Analysis 2026-2034

The biopsy devices market globally, in terms of size, is anticipated to show growth over the forecast period. This is due to the rising prevalence of cancer, the need to perform early diagnosis, the need to make diagnosis accurate, and the development of minimally invasive medical devices. The rising practice of image-guided biopsy, the development of healthcare infrastructure, and the need to make the procedure accurate contribute to growth in the market. Thus, the market, which stood at US$ 3.02 Billion in 2025, is anticipated to register growth to US$ 5.02 Billion in 2034, with a Compound Annual Growth Rate (CAGR) of 5.81% over the period 2026-2034.

Global Biopsy Devices Market Outlook

Biopsy devices are specialized medical tools designed for the extraction of tissue or cell samples of the human body for diagnostic analysis and are mostly employed for the identification of abnormal cell behavior, cancer, and viral or bacterial attacks. Biopsy tools help surgeons collect tissue samples from regions of the human body such as the breast, lung, prostate, liver, and bone marrow. The most common type of tool comprises needles and forceps, including drills and vacuum-assisted methods of extraction combined with medical imaging modalities such as ultrasound, computer tomography scans, magnetic resonance imaging scans, and mammography scans. Biopsy tools are known for providing comfort and lowering the chances of complications, thereby lowering recovery times after extraction of samples compared with traditional biopsies.

Biopsy devices have become increasingly popular around the globe due to the increasing demand for early and precise disease diagnosis. The prevalence of cancer and other diseases is increasing around the world, and hence, there is a growing need for timely and precise diagnosis of such diseases. Moreover, the growing population of seniors and a greater focus on preventive healthcare have also fueled the demand for such medical products and devices. Finally, increasing healthcare infrastructure is also a notable contributing fact to the ever-increasing demand for biopsy products and tools around the globe.

Growth Drivers of the Global Biopsy Devices Market

Rising Prevalence of Cancer and Chronic Diseases

The global incidence of various kinds of cancers is considered to be the major factor contributing to the growth of the biopsy devices market. Various types of breast, pulmonary, prostate, colon, liver, and so on, are some kinds of tumors where, for proper diagnosis, tissue samples have to be collected. The effectiveness of biopsy systems cannot be undermined, as besides cancer treatments, various kinds of inflammatory, infectious, and autoimmune diseases are usually detected through them. The global prevalence of various kinds of diseases due to aging, lifestyle, and exposure to diseases is also contributing to the growth of the market. The need for effective systems to diagnose diseases, particularly through the adoption of various kinds of biopsy systems, also increases. For 2022, an estimated 20 million new cancer cases and 9.7 million deaths are expected, while the number of individuals who were alive within 5 years following a cancer diagnosis has been estimated to be 53.5 million. One in five develop cancer during their lifetime, while about one in nine men and one in twelve women die from the disease. It is anticipated that by 2050, the rate of new cancer cases per year will reach a high of 33 million with cancer-related deaths reaching 18.2 million annually.

Advancements in Minimally Invasive and Image-Guided Technologies

Technological advancements have played a significant role in increasing the safety, accuracy, and efficacy of biopsy procedures, thus driving the overall biopsy device market growth. Biopsy procedures are becoming more minimally invasive due to advances in technology. This makes the procedures more painless and reduces the overall recovery and complication risks associated with the procedures. When the biopsy devices were combined with the capabilities of imaging diagnostic equipment such as ultrasound, CT scans, MRI scans, and mammographs, the overall diagnostic power of the procedures increased considerably. This led to increased physician confidence and the overall success rates of the procedures. With the overall move of the clinical community to more minimally invasive diagnostic procedures, the global demand for technologically advanced biopsy procedures has been thriving. January 2025: IAC is delighted to announce the availability of the IAC Standards for MRI Image-Guided Prostate Biopsy Procedures as the basis of the new MRI Image-Guided Procedure accreditation program now available to facilities wishing to apply.

Expansion of Healthcare Infrastructure and Diagnostic Services

The increasing trend of developing new healthcare infrastructure, especially in new economies, is creating a positive market prospect for the global market of biopsy devices. Many private and government organizations and public and private enterprises have invested heavily in developing new hospitals and imaging facilities along with additional operating rooms for cancer patients. Overall access to new imaging and medical professionals is creating a positive market trend for this market as a whole. Many public/private organizations and government bodies have become alert and have launched public awareness programs to spread education about cancer and imaging diagnosis among the population. Because of such factors, the demand for biopsy equipment is increasing and will grow in the future. July 2025, “In our quest for providing access to faster and better molecular information for our patients, and as a further extension of our focus on companion diagnostics and supportive clinical and scientific research, we are proud to announce our second Genexus system launched in association with FMRI,” says Mr. Ashit Pai, CEO of Agilus Diagnostics.

Challenges of the Global Biopsy Devices Market

High Cost of Advanced Biopsy Devices and Procedures

Cost could be one of the major hurdles that the global biopsy devices market may face; the cost of the superior technology and procedures drives up the cost of the device considerably. With the necessity of image-guidance and the use of the device as well as the equipment itself producing the results of the procedures performed on the device, the cost factor acts as a major hindrance. This factor could prove to be a major problem due to the prevalence of cost sensitivity among the patients of these countries. Many of the countries may be unable to afford the superior technology and procedures offered by the device. This could drive down the demand for the device considerably.

Risk of Complications and Regulatory Constraints

While the procedure is quite safe, it is naturally accompanied by certain risks, including bleeding, pain, or damage to the tissues, all of which may weigh in the minds of patients while accepting the procedure. In some rare cases, the problems accompanying the procedure might necessitate additional medical interventions, thereby adding to the costs. Equally interesting is the fact that the devices used in the biopsy procedure fall under the category of regulated medical product approvals, where the medical device manufacturers are challenged to prove the safety and efficacy of the medical device, thereby creating international hurdles in product launches, where manufacturers might incur additional costs during the product-development process in terms of abiding by the country-specific regulations.

Biopsy Needles Market

The biopsy needles market can be considered one of the most vital markets in the biopsy devices market. This is mainly because biopsy needles are employed in large quantities in the extraction of tissue or cell matter from internal organs such as the breast, prostate, liver, kidney, and lungs. This market can be attributed to the high reliance being shown in favor of minimally invasive diagnostic techniques in modern times. The minimization of elements of discomfort and health complications presents biopsy needles as a promising market in the biopsy devices market. The employment of biopsy needles has played a vital supportive role in bringing about a degree of precision in diagnostic procedures. The disposable form of biopsy needles has gained prominence in favor of lowering the incidence of diseases caused by cross-contaminated needles. The high cost-effectiveness of biopsy needles has ensured that it becomes a cornerstone in diagnostic procedures.

Prostate Biopsy Devices Market

The demand for prostate biopsy instruments is on the rise owing to the prevalence of prostate-related diseases and the increasing cases of prostate cancer among aging male populations. Prostate biopsy plays a significant role as a diagnostic tool to detect suspected cases of malignancies after abnormal tests of prostate-specific antigens. Advanced prostate biopsy technology has reduced the infection rate to a considerable degree. There has also been increased awareness of prostate-related diseases and the implementation of efficient biopsies to detect abnormalities accurately. This factor contributes to the increasing demand for more precise prostate biopsy equipment. Hospitals and specialty diagnostic clinics are opting to utilize the best available prostate biopsy equipment to facilitate diagnostic procedures. Early detection of the condition of the patient contributes to the effectiveness of the treatment provided.

Lung Biopsy Devices Market

The lung biopsy devices market is growing as the incidence of lung cancer and other respiratory conditions is progresses in the world population. Lung biopsy is a diagnostic tool of immense value in order to confirm a case of lung cancer, its histopathologic type, and type of treatment required for the patient in the future, among several reasons. CT, as well as bronchoscopic, guidance for lung biopsy procedures can now be conducted more successfully, thereby ensuring a higher degree of diagnostic accuracy and minimum in-procedure complications such as pneumothorax and hemorrhage, through recent improvements in biopsy needle, forceps, and minimally invasive devices, in general, and the lung biopsy devices space, in particular. Smoking, as well as environmentally driven, respiratory-related conditions continue to gain ground, ensuring that the lung biopsy devices market maintains its growth trajectory in the days ahead as well.

Biopsy CT Scan Devices Market

The biopsy CT scan device market segment can be considered essential in facilitating the diagnosis of conditions by accurately obtaining biopsy samples in a non-invasive manner. By utilizing the biopsy device, accurately targeting hard-to-reach tumor or cancer locations in vital organs like the lungs, liver, pancreas, and the bone structure can be accomplished. The accuracy of the biopsy results can be enhanced owing to the high-resolution imaging capabilities of the CT scan, thereby improving the overall diagnostic results. The adoption of cancer diagnostic procedures and advancements in imagery-based diagnostic techniques have supported the demand for performing biopsy, or needle, procedures, where the imaging results provided by the aforementioned technique have been found to be highly effective. Even though the utilization of the biopsy needle device requires high capital costs, its accuracy in providing results makes it essential in the overall diagnostic process of highly sophisticated and technologically driven facilities.

Biopsy Devices Diagnostic & Imaging Center Market

Diagnostic and imaging centers form another major end-user segment of the biopsy devices market. Diagnostic and imaging centers provide facilities for diagnostic and healthcare services on an out-patient basis, which is becoming increasingly popular these days. Diagnostic and imaging centers specialize in image-guided biopsy procedures, which is more efficient and cost-effective. Moreover, the rising demand and acceptance of minimally invasive diagnostic and image-guided diagnostic procedures have fueled the growth and acceptance of diagnostic centers among patients and users. Diagnostic and imaging centers are equipped with advanced diagnostic technologies, including ultrasound, CT scans, and MRI scans, which enhance and support the success of biopsy and biopsy devices. Moreover, the establishment and widening of private diagnostic sectors, especially in the urban and semi-urban regions, have significantly fueled the growth and acceptance of the biopsy devices market.

USA Biopsy Devices Market

Biopsy devices in the United States represent a sizable share of the biopsy market globally due to a strong healthcare infrastructure, a high incidence rate of cancer, and a strong demand for minimally invasive biopsy detection systems. A lot of biopsy-related procedures are carried out every year for cancers in various states, including breast, colorectal, lung, and prostate cancers. A lot of technological advancements can be attributed to biopsy devices, enabling better diagnostic capabilities for Healthcare Professionals. Advances in imaging capabilities, along with a favorable reimbursement scenario, make it an important market for biopsy needles, guns, and systems. Despite the high prices of biopsy devices, medical researchers and medical professionals remain keen because of the high potential for technological advancements in medical devices. May 2025: BiBB Instruments AB and TaeWoong Medical USA sign a Letter of Intent to collaborate for promoting, distributing, and commercializing the existing EndoDrill GI Biopsy Systems in the medical segment within the U.S. market.

United Kingdom Biopsy Devices Market

Strong public healthcare and a greater focus on the early diagnosis of diseases are driving the demand for the UK biopsy devices market. NHS authorities actively advocate cancer-screening programs, especially for breast, prostrate, and lung cancers, further supporting stable demand for biopsy procedures. Minimally invasive and image-guided biopsy techniques are showing an increasing growth curve as healthcare providers try to enhance diagnostic accuracy while minimizing patient trauma. Technological up-gradation in diagnostic imaging and pathology services is widening the efficiency of biopsy across hospitals and diagnostic centers. Budget constraints related to the public health care system can prohibit the rapid adoption of high-cost devices; however, continuous modernization and partnerships with private diagnostics providers would account for strong market demand. The increasing incidence of cancer and aging population results in continuously growing demand for dependable, cost-efficient biopsy devices across the United Kingdom. July 2025, Olympus Corporation (Olympus), a global MedTech company committed to making people's lives healthier, safer and more fulfilling announced the launch of SecureFlex, a single-use fine needle biopsy device, in EMEA.

India Biopsy Devices Market

The India biopsy devices market is showing strong growth, driven by increasing cancer incidence, healthcare infrastructure expansion, and growing early diagnosis awareness. Government initiatives and private investments are essentially expanding access to diagnostic services in urban and semi-urban areas. Diagnostic laboratories and imaging centers are rapidly expanding, thereby driving demand for affordable and efficient biopsy devices. Cost-effective biopsy needles and minimally invasive systems hold the greatest demand in the Indian market. While coverage of reimbursement and affordability is relatively low in certain areas, the growth in medical tourism and adoption of advanced diagnostic technologies is driving market growth. Growing training of healthcare professionals and availability of imaging-guided biopsy procedures are further improving diagnostic accuracy. India is thus expected to remain a high-growth market for biopsy devices as access to healthcare continues to improve. Dec 2024, PanGIA Biotech, a pioneer in liquid biopsy technology, announced its first international partnership with Canary Oncoceutics. This deal launches the PanGIA Prostate Assay, the world's first artificial intelligence-integrated urine-based liquid biopsy for the detection of prostate cancer, into India for the first time commercially.

Saudi Arabia Biopsy Devices Market

The Saudi Arabian biopsy devices market is expanding favorably due to increasing healthcare expenditures and awareness of the diagnosis of cancer. Also, the government programs to upgrade the overall standard of the healthcare system, combined with the construction of state-of-the-art hospitals and diagnostic clinics, are major factors contributing to the increasing demand for advanced diagnostics equipment. Lifestyle-related diseases and the aging population also serve to boost the demand for precise diagnostic procedures. Hospitals and diagnostic clinics are increasingly opting to employ image-guidance modalities of biopsy equipment to enhance the success rate of diagnostic procedures. Imported state-of-the-art equipment dominates the biopsy devices segment of the Saudi Arabian medical device industry. However, the significant cost of the equipment and the need to import state-of-the-art equipment may pose a problem to the biopsy devices segment of the Saudi Arabian medical device industry. Announced in February 2025, some of the key healthcare investments involving Saudi Arabia included the new Oncology Center of Excellence facility by Johns Hopkins Aramco Healthcare, as well as the major expansion of Aster Pharmacy.

Market Segmentation

Product

• Needle-Based Guns
• Biopsy Guidance Systems
• Biopsy Needles
• Biopsy Forceps
• Others

Application

• Breast Biopsy
• Lung Biopsy
• Prostate Biopsy
• Liver Biopsy
• Gastroenterology Biopsy
• Others

Technology

• CT Scan
• Stereotactic Guided
• Ultrasound Guided
• MRI Guided
• Others

End-User

• Hospitals
• Diagnostic & Imaging Center
• Others

Country

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Turkey

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Thailand
• Malaysia
• Indonesia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• South Africa
• Saudi Arabia
• United Arab Emirates

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Company Analysis

• Cardinal Health, Inc.
• Hologic, Inc.
• Danaher Corporation
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Medtronic plc.
• Olympus Corporation
• CONMED Corporation